153 related articles for article (PubMed ID: 15607951)
1. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species.
Fioriti L; Quaglio E; Massignan T; Colombo L; Stewart RS; Salmona M; Harris DA; Forloni G; Chiesa R
Mol Cell Neurosci; 2005 Jan; 28(1):165-76. PubMed ID: 15607951
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126.
Ning ZY; Zhao DM; Liu HX; Yang JM; Han CX; Cui YL; Meng LP; Wu CD; Liu ML; Zhang TX
Cell Mol Neurobiol; 2005 Dec; 25(8):1171-83. PubMed ID: 16388330
[TBL] [Abstract][Full Text] [Related]
3. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
[TBL] [Abstract][Full Text] [Related]
5. Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126.
Sassoon J; Daniels M; Brown DR
Mol Cell Neurosci; 2004 Jan; 25(1):181-91. PubMed ID: 14962751
[TBL] [Abstract][Full Text] [Related]
6. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity of the putative transmembrane domain of the prion protein.
Haïk S; Peyrin JM; Lins L; Rosseneu MY; Brasseur R; Langeveld JP; Tagliavini F; Deslys JP; Lasmézas C; Dormont D
Neurobiol Dis; 2000 Dec; 7(6 Pt B):644-56. PubMed ID: 11114262
[TBL] [Abstract][Full Text] [Related]
8. Humanin rescues cortical neurons from prion-peptide-induced apoptosis.
Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Pillot T
Mol Cell Neurosci; 2004 Jan; 25(1):95-102. PubMed ID: 14962743
[TBL] [Abstract][Full Text] [Related]
9. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM
Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
[TBL] [Abstract][Full Text] [Related]
10. Prion protein peptides: optimal toxicity and peptide blockade of toxicity.
Brown DR
Mol Cell Neurosci; 2000 Jan; 15(1):66-78. PubMed ID: 10662506
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations.
Fioriti L; Dossena S; Stewart LR; Stewart RS; Harris DA; Forloni G; Chiesa R
J Biol Chem; 2005 Mar; 280(12):11320-8. PubMed ID: 15632159
[TBL] [Abstract][Full Text] [Related]
12. Prion protein on astrocytes or in extracellular fluid impedes neurodegeneration induced by truncated prion protein.
Race B; Meade-White K; Race R; Baumann F; Aguzzi A; Chesebro B
Exp Neurol; 2009 Jun; 217(2):347-52. PubMed ID: 19332059
[TBL] [Abstract][Full Text] [Related]
13. Prion neurotoxicity: insights from prion protein mutants.
Solomon IH; Schepker JA; Harris DA
Curr Issues Mol Biol; 2010; 12(2):51-61. PubMed ID: 19767650
[TBL] [Abstract][Full Text] [Related]
14. PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells.
Brown DR; Herms JW; Schmidt B; Kretzschmar HA
Eur J Neurosci; 1997 Jun; 9(6):1162-9. PubMed ID: 9215699
[TBL] [Abstract][Full Text] [Related]
15. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126.
Jobling MF; Huang X; Stewart LR; Barnham KJ; Curtain C; Volitakis I; Perugini M; White AR; Cherny RA; Masters CL; Barrow CJ; Collins SJ; Bush AI; Cappai R
Biochemistry; 2001 Jul; 40(27):8073-84. PubMed ID: 11434776
[TBL] [Abstract][Full Text] [Related]
16. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
17. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
20. Identification of cryptic nuclear localization signals in the prion protein.
Gu Y; Hinnerwisch J; Fredricks R; Kalepu S; Mishra RS; Singh N
Neurobiol Dis; 2003 Mar; 12(2):133-49. PubMed ID: 12667468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
